PFIZER INC - 06 Nov 2025 SCHEDULE 13D/A Report for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Common Stock") (ALLO)

Filing Manager
PFIZER INC
Reporting Manager
Pfizer Inc.
Security
Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Common Stock")
Symbol
ALLO
Shares outstanding
244,800,444 shares
Disclosed Ownership
22,032,040 shares
Ownership
9%
Form type
SCHEDULE 13D/A
Filing time
13 Feb 2026, 17:09:45 UTC
Date of event
06 Nov 2025
SEC
View on sec.gov

Quoteable Key Fact

"PFIZER INC disclosed 9% ownership in Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Common Stock") (ALLO) on 06 Nov 2025."

Quick Takeaways

  • PFIZER INC filed SCHEDULE 13D/A for Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Common Stock") (ALLO).
  • Disclosed ownership: 9%.
  • Date of event: 06 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2026, 17:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Pfizer Inc. 9% 22,032,040 22,032,040 0 /s/ Madelyn D. Purcell Madelyn D. Purcell/Assistant Secretary 0000078003